Zions Bancorporation’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $10.7M | Buy |
115,725
+114
| +0.1% | +$10.3K | 0.67% | 18 |
|
|
2024
Q3 | $9.69M | Buy |
115,611
+7,331
| +7% | +$559K | 0.71% | 15 |
|
|
2024
Q2 | $7.43M | Buy |
108,280
+14,714
| +16% | +$982K | 0.59% | 25 |
|
|
2024
Q1 | $6.85M | Buy |
93,566
+43,358
| +86% | +$3.33M | 0.5% | 27 |
|
|
2023
Q4 | $4.07M | Buy |
50,208
+1,708
| +4% | +$133K | 0.28% | 66 |
|
|
2023
Q3 | $3.63M | Buy |
48,500
+9,012
| +23% | +$693K | 0.32% | 57 |
|
|
2023
Q2 | $3.04M | Sell |
39,488
-24,991
| -39% | -$1.99M | 0.26% | 71 |
|
|
2023
Q1 | $5.35M | Sell |
64,479
-42,774
| -40% | -$3.54M | 0.46% | 34 |
|
|
2022
Q4 | $9.21M | Sell |
107,253
-10,849
| -9% | -$859K | 0.73% | 16 |
|
|
2022
Q3 | $7.29M | Buy |
118,102
+9,246
| +8% | +$583K | 0.76% | 12 |
|
|
2022
Q2 | $6.73M | Buy |
108,856
+26,067
| +31% | +$1.61M | 0.67% | 17 |
|
|
2022
Q1 | $4.92M | Buy |
82,789
+25,677
| +45% | +$1.64M | 0.44% | 27 |
|
|
2021
Q4 | $4.15M | Buy |
57,112
+3,675
| +7% | +$253K | 0.37% | 27 |
|
|
2021
Q3 | $3.73M | Buy |
53,437
+3,694
| +7% | +$260K | 0.38% | 25 |
|
|
2021
Q2 | $3.42M | Buy |
49,743
+4,406
| +10% | +$294K | 0.34% | 26 |
|
|
2021
Q1 | $2.93M | Buy |
45,337
+6,077
| +15% | +$392K | 0.33% | 29 |
|
|
2020
Q4 | $2.29M | Buy |
39,260
+6,237
| +19% | +$376K | 0.29% | 35 |
|
|
2020
Q3 | $2.09M | Buy |
33,023
+20,029
| +154% | +$1.39M | 0.3% | 38 |
|
|
2020
Q2 | $1M | Sell |
12,994
-19,417
| -60% | -$1.49M | 0.15% | 65 |
|
|
2020
Q1 | $2.42M | Buy |
32,411
+7,390
| +30% | +$511K | 0.42% | 22 |
|
|
2019
Q4 | $1.63M | Sell |
25,021
-2,056
| -8% | -$134K | 0.23% | 43 |
|
|
2019
Q3 | $1.72M | Buy |
27,077
+24,474
| +940% | +$1.6M | 0.25% | 38 |
|
|
2019
Q2 | $176K | Sell |
2,603
-41
| -2% | -$2.7K | 0.03% | 245 |
|
|
2019
Q1 | $172K | Buy |
+2,644
| New | +$176K | 0.03% | 244 |
|
|
2018
Q4 | – | Sell |
-3,359
| Closed | -$259K | – | 601 |
|
|
2018
Q3 | $259K | Buy |
+3,359
| New | +$254K | 0.06% | 141 |
|
|
2017
Q4 | – | Sell |
-6,133
| Closed | -$497K | – | 754 |
|
|
2017
Q3 | $497K | Sell |
6,133
-989
| -14% | -$75.6K | 0.07% | 156 |
|
|
2017
Q2 | $504K | Sell |
7,122
-1,013
| -12% | -$67.4K | 0.09% | 106 |
|
|
2017
Q1 | $550K | Sell |
8,135
-4,049
| -33% | -$285K | 0.1% | 82 |
|
|
2016
Q4 | $873K | Sell |
12,184
-477
| -4% | -$35.5K | 0.15% | 72 |
|
|
2016
Q3 | $932K | Buy |
12,661
+193
| +2% | +$15.7K | 0.18% | 71 |
|
|
2016
Q2 | $1.07M | Buy |
12,468
+362
| +3% | +$32.1K | 0.19% | 68 |
|
|
2016
Q1 | $1.17M | Sell |
12,106
-274
| -2% | -$24.7K | 0.21% | 67 |
|
|
2015
Q4 | $1.06M | Buy |
12,380
+2,027
| +20% | +$211K | 0.19% | 68 |
|
|
2015
Q3 | $1.12M | Buy |
+10,353
| New | +$1.15M | 0.21% | 66 |
|
|
2015
Q2 | – | Sell |
-1,223
| Closed | -$120K | – | 448 |
|
|
2015
Q1 | $120K | Buy |
+1,223
| New | +$124K | 0.02% | 155 |
|
Other funds holding GILD
Zions Bancorporation's GILD Position: Q4 2024 in Review
Zions Bancorporation increased its Gilead Sciences (GILD) stake by 0.1% in Q4 2024, buying an estimated $10.3K and bringing the position to 115,725 shares worth $10.7M. The position accounts for 0.67% of the portfolio, ranked #18.
Zions Bancorporation first reported a position in GILD in Q1 2015 and has held it in 35 quarters since. 1,888 funds tracked by Wall St. Rank hold GILD as of Q4 2024.
- Zions Bancorporation held 115,725 shares of Gilead Sciences worth $10.7M as of Q4 2024.
- Zions Bancorporation bought 114 Gilead Sciences shares in Q4 2024, an estimated $10.3K.
- Gilead Sciences made up 0.67% of Zions Bancorporation's portfolio in Q4 2024, its #18 holding.
- Zions Bancorporation first reported a position in Gilead Sciences in Q1 2015 and has held it in 35 quarters since.
- 1,888 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.